Molecular Microbiology- Guided Antimicrobial Stewardship Versus Standard Stewardship in Hospitalized Patients
NCT07684300 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250
Last updated 2026-07-06
Summary
The goal of this clinical trial is to learn whether integrating rapid multiplex molecular microbiology results with predefined clinical and laboratory criteria into an antimicrobial stewardship program improves antimicrobial use in hospitalized adults receiving empiric high-impact antimicrobial therapy.
The main questions it aims to answer are:
Does this strategy reduce the duration of exposure to high-impact antimicrobial therapy compared with standard antimicrobial stewardship practice? Does this strategy improve the appropriateness of antimicrobial treatment? Does this strategy affect clinical outcomes, including hospital readmission, intensive care unit admission, infection recurrence, mortality, and healthcare costs? Researchers will compare a protocolized antimicrobial stewardship strategy that incorporates multiplex molecular microbiology results and predefined clinical criteria with the standard antimicrobial stewardship strategy currently used in the hospital.
Participants will:
Receive antimicrobial management according to the stewardship strategy assigned to their hospital unit during the study period.
Undergo molecular microbiology testing and routine clinical and laboratory assessments as part of standard hospital care when indicated.
Be followed to evaluate antimicrobial exposure, treatment appropriateness, safety outcomes, hospital readmission, intensive care unit admission, infection recurrence, mortality, and healthcare costs.
Conditions
- Infection
- Antimicrobial Stewardship Program
- Antimicrobial Resistance
- Multiplex PCR
Interventions
- BEHAVIORAL
-
Protocolized Antimicrobial Stewardship Strategy
A standardized antimicrobial stewardship strategy integrating multiplex molecular microbiology results with predefined clinical and laboratory criteria to support antimicrobial prescribing decisions.
- BEHAVIORAL
-
Standard Antimicrobial Stewardship
Routine antimicrobial stewardship practice based on standard clinical assessment and conventional microbiological information.
Sponsors & Collaborators
-
Maria Espinosa Perez
lead OTHER
Principal Investigators
-
Mar Masiá Canuto, MD, PhD · Hospital General Universitario de Elche / Universidad Miguel Hernández
-
Félix Gutiérrez Rodero, MD, PhD · Hospital General Universitario de Elche / Universidad Miguel Hernández
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-10
- Primary Completion
- 2027-04-30
- Completion
- 2027-06-30
Countries
- Spain
Study Locations
More Related Trials
-
Antimicrobial Stewardship Reduces MDRO Isolates in Critically Ill Patients
NCT02128399 ·Status: COMPLETED
-
Predictive Score in Patients With Hematological Malignancies Colonized by Multidrug-resistant Enterobacteriaceae
NCT07396571 ·Status: NOT_YET_RECRUITING
-
Evaluation of the Potential Impact of Computerized Antimicrobial Stewardship
NCT04328090 ·Status: COMPLETED ·Phase: NA
-
Merck IISP Stewardship Grant for Antibiotic Best Practices
NCT01573195 ·Status: COMPLETED
-
Approach for Optimizing Meropenem Therapy in Intubated and Mechanically-Ventilated, Adult Patients With Severe Gram-Negative Lower Respiratory Tract Infection
NCT03915236 ·Status: TERMINATED ·Phase: NA
-
Using Antibiotics Wisely - An Antimicrobial Stewardship Program
NCT04388293 ·Status: UNKNOWN
-
Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit
NCT05696093 ·Status: RECRUITING ·Phase: PHASE3
-
Pivotal Study in Nosocomial Pneumonia Suspected or Confirmed to be Due to Pseudomonas
NCT03582007 ·Status: TERMINATED ·Phase: PHASE3
-
Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria
NCT07512596 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies
NCT04335383 ·Status: RECRUITING
-
Co-infection Management in COVID-19 Critically Ill
NCT04382092 ·Status: COMPLETED ·Phase: NA
-
Polymyxin B Monotherapy vs Combination Therapy in Critically Ill Patients With Multi-drug Resistant Pathogens
NCT03159078 ·Status: UNKNOWN ·Phase: PHASE3
-
Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Immunocompromised Patients With Hospital-acquired Pneumonia Requiring Mechanical Ventilation
NCT05405491 ·Status: RECRUITING ·Phase: NA
-
MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia
NCT07492771 ·Status: RECRUITING ·Phase: PHASE1
-
Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU
NCT00307099 ·Status: TERMINATED ·Phase: PHASE3
-
Comparison of Two Protocols to Prevent the Acquisition of Methicillin-Resistant Staphylococcus Aureus.
NCT00151606 ·Status: COMPLETED ·Phase: NA
-
Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia
NCT04334850 ·Status: COMPLETED ·Phase: NA
-
Nitazoxanide Therapy for Patients With COVID-19 Pneumonia
NCT04561219 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Outcomes in Patients With Infection by Resistant Microorganism
NCT05880069 ·Status: UNKNOWN
-
Standard Precautions Versus Contact Additional Precautions Against Multi-drug Resistant Bacteria in Intensive Care Unit (PSBMR)
NCT02890433 ·Status: COMPLETED
-
Biomarker Signature-Supported Antibiotic Treatment Decisions in ICU
NCT07481773 ·Status: RECRUITING ·Phase: NA
-
Ceftobiprole in Hospital Acquired Pneumonia
NCT00229008 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Number of Rank of B-lactam Antibiotics on Emergence on Multidrug Resistant Bacteria
NCT03752476 ·Status: UNKNOWN
-
Incidence of Colonization by Multidrug-resistant Organisms in Mechanically Ventilated Patients With Severe COVID-19
NCT05293418 ·Status: COMPLETED
-
Optimizing Clinical Use of Polymyxin B
NCT02682355 ·Status: COMPLETED